End of BMW Z4 Production Paves Way for Toyota-BMW Joint Sports Car

Successor could be named Z5
Writer
2012 BMW Z4 sDrive28i left front 1

After seven years of production, BMW quietly snuffed out the Z4 roadster from its lineup. According to a report fromBimmer Today,on August 22, a Valencia Orange Metallic Z4 sDrive35is left the Regensburg plant as the final example of BMW's once-popular roadster.

The first generation of Z4 proved popular, but the second-gen model didn't maintain the same momentum. During its production run, a little more than 113,000 were produced globally, and the U.S. sales were rather dismal. In 2015, BMW only sold 1,829 Z4s while Mercedes moved 4,182 SLKs.

ADVERTISEMENT - CONTINUE READING BELOW
2012 BMW Z4 sDrive28i rear 1 660x413

This lack of popularity wasn't due to a lack of performance, however. The Z4 was the only model to still pack power from the single-turbo N54 inline-six. In range-topping 35is spec, the 3.0-liter pumped out 335 hp and 332 lb-ft of torque, enough to shuffle the Z4 to 60 mph in just 4.6 seconds.

Fans need not pout for too long, as BMW has consistently made moves toward a successor in the near future. The joint venture between Toyota and BMW has yet to bear fruit, but we expect to see a Z4 successor based on the bones of the upcoming Toyota-BMW Supra joint sports car. Again, no concrete details have surfaced, but we've heard reports ranging from classic turbocharged inline-six-cylinder power to a new hybrid drivetrain. The Supra/Z5 will most likely be built by Magna Steyr in Graz, Austria.

ADVERTISEMENT - CONTINUE READING BELOW

Source: Bimmer Today

Stay Ahead of the Curve.

Get the newest car reviews, hottest auto news, and expert analysis of the latest trends delivered straight to your inbox!

By signing up, I agree to the Terms of Use (including the dispute resolution procedures) and have reviewed the Privacy Notice.
ADVERTISEMENT - CONTINUE READING BELOW

You May Also Like

Related Pages

Related MotorTrend Content: World | Entertainment | News: News | Tech | Health | Politics